Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis

Post time 2022-11-28 18:20:15

journal：Neuro-Oncology

Authors：Florence Oberkampf; Maya Gutierrez; Olfa Trabelsi Grati; Emilie Le Rhun; Olivier Trédan; Isabelle Turbiez; Amir Kadi; Coraline Dubot; Sophie Taillibert; Sophie Vacher; Claire Bonneau

Published date：--

DOI：10.1093/neuonc/noac180

Article link：http://dx.doi.org/10.1093/neuonc/noac180

Article Source：Oxford University Press (OUP)。

Remark：

Post time 2022-11-28 18:20:16

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Oxford] Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Oxford] Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Oxford] Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis